Patented Medicine Prices Review Board
February 22, 2006 Meeting
At its meeting, the Board
- was briefed on ongoing initiatives:
- National Pharmaceuticals Strategy (PMPRB is an observer);
- Monitoring and Reporting on Non-Patented Prescription Drug Prices under NPS; and
- NPDUIS.
- approved the next steps for the upcoming consultations on the Board´s Excessive Price Guidelines (Guidelines).
The next Board meeting is scheduled for May 17 -18, 2006. For additional information, please contact the Secretary of the Board at: 1-877-861-2350, or (613) 954-8299, or at sdupont@pmprb-cepmb.gc.ca. |